First we compared the distribution of LaNt α31 and LMα3 in a pilot panel of four normal (Fig 1A), four invasive ductal carcinoma (Fig 1B) and four invasive ductal carcinoma that were triple negative for ER, PR, and Her2 (Fig 1C). This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.